Spontaneous regression of an asymptomatic meningioma associated with discontinuation of progesterone agonist administration - Case report

Neurologia Medico-Chirurgica

Volumn 48, Issue 5, 2008, Pages 227-230

  Shimizu, Jun ^a,b   Matsumoto, Masayoshi ^a   Yamazaki, Etsuo ^a   Yasue, Masaharu ^a  

^a JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^b JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Asymptomatic meningioma; Progesterone agonist; Prostate; Spontaneous regression

Indexed keywords

CHLORMADINONE ACETATE; GADOLINIUM; NAFTOPIDIL;

AGED; ARTICLE; BRAIN; BRAIN TUMOR; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONSERVATIVE TREATMENT; DIZZINESS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FOLLOW UP; FRONTAL LOBE; HEAD INJURY; HISTORY; HORMONAL THERAPY; HOSPITAL; HUMAN; MALE; MASS; MENINGIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTPATIENT; PRESCRIPTION; PROSTATE DISEASE; PROSTATE HYPERTROPHY; REMISSION; SPHENOID; TRAFFIC ACCIDENT;

AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; CHLORMADINONE ACETATE; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; NEOPLASM REGRESSION, SPONTANEOUS; PROGESTERONE; PROSTATIC HYPERPLASIA;

EID: 44349101126     PISSN: 04708105     EISSN: 13498029     Source Type: Journal    
DOI: 10.2176/nmc.48.227     Document Type: Article

References (23)

1. Brandis A, Mirzai S, Tatagiba M, Walter GF, Samii M, Ostertag H: Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features. Neurosurgery 33: 212-217, 1993
2. Committee of Brain Tumor Registry of Japan: Report of Brain Tumor Registry of Japan (1969-1996), 11th edition. Neurol Med Chir (Tokyo) 43 Suppl: i-vii, 1-111, 2003
3. DeAngelis LM: Brain tumors. N Engl J Med 344: 114-123, 2001
4. Durmaz R, Deliorman S, Isiksoy S, Uyar R, Tel E: Luteinizing hormone releasing hormone increases proliferation of meningioma cells in vitro. Arch Physiol Biochem 107: 286-291, 1999
5. Fushimi S, Fukuchi M, Yonetani M: [Remarkable regression of right frontal base meningioma with termination of anti-testosterone agent. Case report] (author's translation). Akitaken Nouson Igakukai Zasshi 2: 91, 2004 (Jpn, with no abstract)
6. Gruber T, Dare AO, Balos LL, Lele S, Fenstermaker RA: Multiple meningiomas arising during long-term therapy with the progesterone agonist megasterol acetate. Case report. J Neurosurg 100: 328-331, 2004
7. Grunberg SM, Weiss MH, Russell CA, Spitz IM, Ahmadi J, Sadun A, Sitruk-Ware R: Long-term administration of mifepristone (RU486): clinical tolerance during extended treatment of meningioma. Cancer Invest 8: 727-733, 2006
8. Grunberg SM, WeissMH, Spitz IM, Ahmadi J, Sadun A, Russell CA: Treatment of unresectable meningiomas with the antiprogesterone agent mifepristone. J Neurosurg 74: 861-866, 1991
9. Hsu DW, Efird JT, Edley-Whyte ET: Progesterone and estrogen receptors in meningiomas: prognostic considerations. J Neurosurg 86: 113-120, 1997
10. Konstantinidou AE, Korkopoulou P, Mahera H, Hranioti S, Eftychiadis C, Patsouris E: Hormone receptors in non-malignant meningiomas correlate with apotosis, cell proliferation and recurrence-free survival. Histopathology 43: 280-290, 2003
11. Kuratsu J, Kochi M, Ushio Y: Incidence and clinical features of asymptomatic meningiomas. J Neurosurg 92: 766-770, 2000
12. Lee KL, Terris MK: Luteinizing hormone-releasing hormone agonists and meningioma: a treatment dilemma. Urology 62: 351i-351iii, 2003
13. Markwalder TM, Gerber HA, Waelti E, Schaffner T, Markwalder RV: Hormonotherapy of meningiomas with medroxyprogesterone acetate. Immunohistochemical demonstration of the effect of medroxyprogesterone acetate on growth fractions of meningioma cells using the monoclonal antibody Ki-67. Surg Neurol 30: 97-101, 1988
14. Markwalder TM, Seiler RW, Zava DT: Antiestrogenic therapy of meningiomas - a pilot study. Surg Neurol 24: 245-249, 1985
15. Markwalder TM, Waelti E, Konig MP: Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Effect of MPA on receptor status of meningioma cytosols. Surg Neurol 28: 3-9, 1987
16. Matsuda Y, Kawamoto K, Kiya K, Kurisu K, Sugiyama K, Uozumi T: Antitumor effects of antiprogesterones on human meningioma cells in vitro and in vivo. J Neurosurg 80: 527-534, 1994
17. Matsumoto M, Sanpei K, Ohishi H, Seiki Y, Terao H, Kudo M: [Spontaneous regression of a meningioma in Meckel's cave. Case report]. Neurol Med Chir (Tokyo) 28: 925-929, 1988 (Jpn, with Eng abstract)
18. Nakamura M, Roser F, Michel J, Jacobs C, Samii M: The natural history of incidental meningiomas. Neurosurgery 53: 62-70, 2003
19. Olson JJ, Beck DW, Schlechite J, Loh PM: Hormonal manipulation of meningioma in vitro. J Neurosurg 65: 99-107, 1986
20. Schrell UM, Adams EF, Fahlbusch R, Greb R, Jirikowski G, Prior R, Ramalho-Ortigao FJ: Hormonal dependency of cerebral meningiomas. Part 1: Female sex steroid receptors and their significance as specific markers for adjuvant medical therapy. J Neurosurg 73: 743-749, 1990
21. Smith JS, Hinojosa AQ, Smith MH, Bollen AW, McDermott MW: Sex steroid and growth factor profile of a meningioma associated with pregnancy. Can J Neurol Sci 32: 122-127, 2005
22. Waelti ER, Markwalder TM: Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Effect of MPA on growth of primary meningioma cells in monolayer tissue culture. Surg Neurol 31: 96-100, 1989
23. Yano S, Kuratsu J; Kumamoto Brain Tumor Research Group: Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience. J Neurosurg 105: 538-543, 2006